BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17176317)

  • 1. Outcomes of 122 diverse adult and pediatric cord blood transplant recipients from a large cord blood bank.
    Ballen KK; Haley NR; Kurtzberg J; Lane TA; Lindgren BR; Miller JP; Newman B; McCullough J
    Transfusion; 2006 Dec; 46(12):2063-70. PubMed ID: 17176317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unrelated cord blood transplant experience by the pediatric blood and marrow transplant consortium.
    Yu LC; Wall DA; Sandler E; Chan KW; Grayson G; Kletzel M
    Pediatr Hematol Oncol; 2001 Jun; 18(4):235-45. PubMed ID: 11400647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group.
    Gluckman E; Rocha V; Boyer-Chammard A; Locatelli F; Arcese W; Pasquini R; Ortega J; Souillet G; Ferreira E; Laporte JP; Fernandez M; Chastang C
    N Engl J Med; 1997 Aug; 337(6):373-81. PubMed ID: 9241126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unrelated umbilical cord blood transplantation for adults with haematological malignancies: results from a single Australian centre.
    Bradstock KF; Hertzberg MS; Kerridge IH; Svennilson J; McGurgan M; Huang G; Antonenas V; Gottlieb DJ
    Intern Med J; 2006 Jun; 36(6):355-61. PubMed ID: 16732860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single versus double unrelated umbilical cord blood units for allogeneic transplantation in adults with advanced haematological malignancies: a retrospective comparison of outcomes.
    Bradstock K; Hertzberg M; Kerridge I; Svennilson J; George B; McGurgan M; Huang G; Antonenas V; Gottlieb D
    Intern Med J; 2009 Nov; 39(11):744-51. PubMed ID: 19220530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of the cord blood transplantation study (COBLT): outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases.
    Martin PL; Carter SL; Kernan NA; Sahdev I; Wall D; Pietryga D; Wagner JE; Kurtzberg J
    Biol Blood Marrow Transplant; 2006 Feb; 12(2):184-94. PubMed ID: 16443516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of unrelated umbilical cord blood transplantation for X-linked adrenoleukodystrophy.
    Beam D; Poe MD; Provenzale JM; Szabolcs P; Martin PL; Prasad V; Parikh S; Driscoll T; Mukundan S; Kurtzberg J; Escolar ML
    Biol Blood Marrow Transplant; 2007 Jun; 13(6):665-74. PubMed ID: 17531776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cord blood transplant in childhood ALL.
    Sawczyn KK; Quinones R; Malcolm J; Foreman N; Garrington T; Gore L; Gao D; Giller R
    Pediatr Blood Cancer; 2005 Dec; 45(7):964-70. PubMed ID: 15929135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome following unrelated cord blood transplant in 136 patients with malignant and non-malignant diseases: a report from the Australian and New Zealand children's haematology and oncology group.
    Petterson TE; Gabriel M; Tiedemann K; Teague L; Shaw PJ; Baker D; Bolton-Jones R; Tapp H; Oswald C; Vowels MR; O'Brien TA
    Bone Marrow Transplant; 2009 Feb; 43(3):207-15. PubMed ID: 18806837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation.
    Rodrigues CA; Sanz G; Brunstein CG; Sanz J; Wagner JE; Renaud M; de Lima M; Cairo MS; Fürst S; Rio B; Dalley C; Carreras E; Harousseau JL; Mohty M; Taveira D; Dreger P; Sureda A; Gluckman E; Rocha V
    J Clin Oncol; 2009 Jan; 27(2):256-63. PubMed ID: 19064984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of unrelated donor umbilical cord blood transplantation for 30 adults with hematological malignancies.
    Kobayashi K; Maeda Y; Hara Y; Nishie-Kataoka M; Nishimori H; Sugiyama H; Namba N; Kubonishi S; Niiya M; Shinagawa K; Ikeda K; Tanimoto M
    Anticancer Res; 2009 May; 29(5):1763-70. PubMed ID: 19443401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unrelated cord blood transplantation in pediatric patients: a report from Saudi Arabia.
    Ayas M; Al-Seraihi A; Al-Jefri A; Al-Ahmari A; Al-Mahr M; Al-Ghonaium A; Al-Muhsen S; Al-Mousa H; Al-Dhekri H; Alsaud B; Eldali A; Mohamad A; Al-Humaidan H; Chadrawi A; Al-Kaff M; Al-Hassnan Z; El-Solh H
    Bone Marrow Transplant; 2010 Aug; 45(8):1281-6. PubMed ID: 20010867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus and methotrexate for the prophylaxis of graft-versus-host disease after unrelated donor cord blood transplantation for adult patients with hematologic malignancies.
    Mori T; Aisa Y; Nakazato T; Yamazaki R; Shimizu T; Mihara A; Yamane A; Ikeda Y; Okamoto S
    Transplant Proc; 2007 Jun; 39(5):1615-9. PubMed ID: 17580201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus as prophylaxis for acute graft-versus-host disease in reduced intensity cord blood transplantation for adult patients with advanced hematologic diseases.
    Miyakoshi S; Kami M; Tanimoto T; Yamaguchi T; Narimatsu H; Kusumi E; Matsumura T; Takagi S; Kato D; Kishi Y; Murashige N; Yuji K; Uchida N; Masuoka K; Wake A; Taniguchi S
    Transplantation; 2007 Aug; 84(3):316-22. PubMed ID: 17700155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
    Heinzelmann F; Lang PJ; Ottinger H; Faul C; Bethge W; Handgretinger R; Bamberg M; Belka C
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):523-8. PubMed ID: 17869449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unrelated cord blood and mismatched unrelated volunteer donor transplants, two alternatives in patients who lack an HLA-identical donor.
    Ringdén O; Okas M; Uhlin M; Uzunel M; Remberger M; Mattsson J
    Bone Marrow Transplant; 2008 Nov; 42(10):643-8. PubMed ID: 18762760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005].
    Faber E; Koza V; Vítek A; Mayer J; Sedlácek P; Zák P; Zapletalová J; Benesová K; Krejcová H; Steinerová K; Maresová I; Cetkovský P
    Vnitr Lek; 2006 Dec; 52(12):1172-80. PubMed ID: 17299910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.
    Shigematsu A; Kondo T; Yamamoto S; Sugita J; Onozawa M; Kahata K; Endo T; Shiratori S; Ota S; Obara M; Wakasa K; Takahata M; Takeda Y; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
    Biol Blood Marrow Transplant; 2008 May; 14(5):568-75. PubMed ID: 18410899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.